The Board of Directors of Stemline Therapeutics, Inc. (the “Company”) sets high standards for the Company's employees, officers, and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.
At Stemline Therapeutics, our Board of Directors strives to address any and all comments, concerns, and questions in a timely manner. To expedite the process, we ask that all communications be addressed to:
750 Lexington Avenue, 11th Floor
New York, NY 10022
These communications may be submitted anonymously or confidentially. If you choose, you may also indicate whether you are a shareholder, customer, supplier, or other interested party. Submitted communications are then distributed to our Board members or to the appropriate individuals, depending on the facts and circumstances outlined within.
The Stemline Therapeutics Board of Directors has requested that the following items, which are unrelated to the duties and responsibilities of the Board, are excluded:
New product suggestions
Résumés and other forms of job inquiries
Business solicitations or advertisements
Additionally, material that is unduly hostile, threatening, illegal, or similarly unsuitable is to be excluded with the provision that these communications must remain available to any non-management director upon request.
Individuals may also communicate online with our Board of Directors as a group using the form below.